Vestcor Inc’s Pacific Biosciences PACB Stock Holding History

Vestcor Inc’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-10,000	Closed	-$51K	–	829
2019 Q4	$51K	Buy	+10,000	New	+$50.8K	﹤0.01%	801

Other funds holding PACB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

KLCMU

Kite Lake Capital Management (UK) London, United Kingdom $125M AUM 198.01% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

WMSA

Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vestcor Inc's PACB Position: Q1 2020 in Review

Vestcor Inc sold out of Pacific Biosciences (PACB) in Q1 2020, closing a stake of 10,000 shares — an estimated $51K sold.

Vestcor Inc first reported a position in PACB in Q4 2019 and held it in 1 quarter. The position peaked at $51K in Q4 2019. 132 funds tracked by Wall St. Rank hold PACB as of Q1 2020.

Vestcor Inc reported no remaining Pacific Biosciences position as of Q1 2020 after selling out during the quarter.
Vestcor Inc sold 10,000 Pacific Biosciences shares in Q1 2020, an estimated $51K.
Vestcor Inc first reported a position in Pacific Biosciences in Q4 2019 and held it in 1 quarter.
Vestcor Inc's Pacific Biosciences position peaked at $51K in Q4 2019.
132 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2020.

Based on Vestcor Inc's 13F filing for Q1 2020, filed 13 May 2020.